Abstract:CD8+ T cells are crucial to establish antitumor immunity, and their high infiltration associates with favorable prognoses. However, several CD8+ T cell subpopulations in the tumor microenvironment may play different roles in prognosis, progression and immunotherapy. Here, we analyzed prior published single-cell RNA-sequencing (scRNA-seq) melanoma data to explore the heterogeneity of CD8+ T cell subpopulations and identified 7 major subpopulations. We found that high infiltration of exhausted CD8+ T cell subpopulation 2 would contribute to unfavorable prognoses. In contrast, a large proportion of naïve/memory cells and cytotoxic CD8+ T cell subpopulation 3 would lead to favorable prognoses. Notably, the proportion of the cytotoxic CD8+ T cell subpopulation 3 would decrease in later-stage melanoma samples, while that of the exhausted CD8+ T cell subpopulation 2 would increase. We also found that high abnormal activities of metabolic pathways existed in exhausted CD8+ T cell subpopulation 1. Significantly, immunosuppressive checkpoints PD-1 and CTLA-4 signaling pathways were up-regulated in exhausted CD8+ T cell subpopulations. Besides, a dynamic transcript landscape of immune checkpoints among different subpopulations was also depicted in this study. Moreover, we identified three overexpressed genes (PMEL, TYRP1, EDNRB) that were significantly correlated to poor prognoses and only expressed in exhausted CD8+ T cell subpopulation 2. Importantly, they showed the highest expression in melanoma samples compared to other tumors. In general, we characterized the CD8+ T cell subpopulations in melanoma and identified that not only genes of immunosuppressive checkpoints but also PMEL, TYRP1, EDNRB could serve as potential targets for melanoma therapy.

Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes

CD8+ T cell states in human cancer: insights from single-cell analysis

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues

Identification of shared characteristics in tumor-infiltrating T cells across 15 cancers

Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer

Spatial features of specific CD103+CD8+ tissue-resident memory T cell subsets define the prognosis in patients with non-small cell lung cancer

CD8<SUP>+</SUP> T cell exhaustion in anti-tumour immunity: The new insights for cancer immunotherapy

Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

CTLs heterogeneity and plasticity: implications for cancer immunotherapy

Unravelling the Heterogeneity and Dynamic Relationships of Tumor-Infiltrating T Cells by Single-Cell RNA Sequencing Analysis

Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy

Heterogeneity and subtypes of CD4+ regulatory T cells: implications for tumor therapy

Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates

Investigating T Cell Immunity in Cancer: Achievements and Prospects

CD8+ T cell differentiation and dysfunction in cancer

The epiphany derived from T-cell-inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responses

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer

The Prognostic and Biology of Tumour-Infiltrating Lymphocytes in the Immunotherapy of Cancer